Profil
Justin Fairchild is currently working as the Vice President of Clinical Development at The Parker Institute For Cancer Immunotherapy.
Prior to this, he worked as the Vice President of Development at Portage Biotech, Inc. from 2022 to 2024.
Mr. Fairchild completed his undergraduate degree at Colgate University and his graduate degree at Johns Hopkins Bloomberg School of Public Health.
Postes actifs de Justin Fairchild
| Sociétés | Poste | Début |
|---|---|---|
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Justin Fairchild
| Sociétés | Poste | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Corporate Officer/Principal | 31/05/2024 |
Formation de Justin Fairchild
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AlphaTON Capital Corp.
AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services Operates cancer research | Commercial Services |
















